ReviewCancers2024

Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance.

Ali Gawi Ermi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.